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Abstract
The dopamine D3 receptor (DRD3) in the ventral striatum is thought to influence motivation and motor functions. Although the expression of DRD3 in the ventral striatum has been shown to exhibit 24-h variations, the mechanisms underlying the variation remain obscure. Here, we demonstrated that molecular components of the circadian clock act as regulators that control the (Ohdo et al., 2011; Paul et al., 2011) .
Synchronized oscillators in peripheral tissues drive energy metabolism, cell division, hormonal secretion, and immune response (Matsuo et al,. 2003; Ishida et al., 2005; Shimba et al., 2005; Hashiramoto et al., 2010) . The core circadian oscillator is composed of interacting positive and negative transcription/translational feedback loops. The CLOCK gene encodes the transcription factor, CLOCK, which dimerizes with BMAL1 to activate the transcription of Period (Per1, Per2) and Cryptochrome (Cry1, Cry2) genes through an E-box enhancer element (Gekakis et al., 1998; Kume et al., 1999) . Once PER and CRY proteins have reached a critical concentration, they attenuate CLOCK/BMAL1 transactivation, thereby generating a 24-h oscillation of their own
transcription. An additional feedback loop that is believed to improve the robustness of the above description involves the orphan nuclear receptor REV-ERBα and the retinoic acid-related orphan receptor (ROR)-α. The interlocked loop, which consists of REV-ERBα and ROR, modulates the This article has not been copyedited and formatted. The final version may differ from this version. transcriptional activity of the Bmal1 gene (Preitner et al., 2002) . These machineries regulate the 24-h variation in output physiology through the periodic expression of clock-controlled genes (Jin et al., 1999; Oishi et al., 2003) .
Dopamine neurons are implicated in the regulation of voluntary movement and motivated behaviors through dopamine receptors (DRs) (Missale et al., 1998) . DRs are grouped into 2 major classes, the D 1 -like receptors (DRD1and DRD5) and the D 2 -like receptors (DRD2, DRD3
and DRD4). The former is coupled to Gαs-proteins, whereas the latter is generally coupled to Gαi-proteins (Civelli et al., 1993; Gingrich et al., 1993) . The dopamine D3 receptor (DRD3) is highly expressed in the ventral striatum, including the nucleus accumbens and the islands of Calleja (Bouthenet et al., 1991; Diaz et al., 2000) . In knockout studies and experiments that have specifically investigated the role of DRD3, it has been postulated that DRD3 may mediate emotional behavior in mice (Xu et al., 1997) . In addition, DRD3 in the ventral striatum has an important role in the treatment of many neurological diseases including depression, schizophrenia and Parkinson's disease (Gurevich et al., 1997; Joyce et al.,2001; Bézard et al., 2003) . Thus, agonists/antagonists with reasonable selectivity for the D3 receptor subtype may improve the symptoms of these diseases. Recently, it has been reported that the levels of expression of DRD3 protein in the mouse striatum exhibit 24-h variations, and this rhythmicity could account for dosing time-dependent changes in the DRD3 agonist quinpirole, which induces This article has not been copyedited and formatted. The final version may differ from this version. locomotor behaviors in mice (Akhisaroglu et al., 2005) . However, the mechanisms underlying the 24-h variation in the levels of DRD3 expression remain unknown.
We describe here a circadian clock-controlled output pathway that promotes the expression of the DRD3 gene. The RORα and REV-ERBα proteins inversely regulate the expression of the DRD3 gene. This is the first description of the mechanism by which transcription of the DRD3 gene is regulated by molecular components of the circadian clock.
This article has not been copyedited and formatted. The final version may differ from this version. weeks before the experiments and killed at 7 weeks old. During the dark period, a dim red light was used to aid treatment (<8 lux). In order to explore the influence of dosing time on the ability of the 7-hydroxy-N,N-dipropyl-2-aminotetralin (7-OH-DPAT) to inhibit the locomotor activity count, 
5′-GACGGCCAGGTCATCACTATT-3′ and 5′-TACCACCAGACAGCACTGTGT-3′. In order to investigate the temporal profiles of the intentional expression of DRD3 mRNA, cell lysates from the ventral striatum of mice were prepared at ZT2, 6, 10, 14, 18, and 22.
Determination of locomotor activity. Locomotor activity data were measured with a photobeam activity system (ACTIMO-100; SHINTECHNO, Fukuoka, Japan), and activity counts were recorded at 1-min intervals. Activity counts were calculated with a moving average with a 30-min window except for the first 5 min; 7-OH-DPAT (10, 50, or 100 μ g/kg, i.p.) was dissolved in saline.
Western blot analysis. In order to investigate the temporal profiles of the intentional expression of DRD3, RORα and REV-ERBα in the mouse ventral striatum, nuclear fractions of the ventral striatum were prepared at ZT2, 6, 10, 14, 18, and 22. Cell membranes or nuclear fractions This article has not been copyedited and formatted. The final version may differ from this version. and sc-899,both from Santa Cruz Biotechnology, Inc.). The molecular weights of DRD3, RORα , and REV-ERVα are 44 kDa, 67 kDa, and 80 kDa, respectively. These antibodies have been used in other published studies (Everett et al., 2010; Bugge et al., 2012; Ozaki et al., 2012) . Specific antigen-antibody complexes were visualized with horseradish peroxidase-conjugated secondary antibodies and Chemi-Lumi One (Nakarai Tesque, Inc., Kyoto, Japan).
Chromatin Immunoprecipitation assay.
In order to analyze the temporal binding of endogenous RORα and REV-ERBα on the DRD3 promoter in the mouse ventral striatum, a chromatin immunoprecipitation (ChIP) assay was performed at ZT2, 10, 14 and 22. Ventral striatum segments were excised and treated with 8% formaldehyde for 5 min at room temperature in order to crosslink the chromatin. Each cross-linked sample was sonicated on ice and then incubated with antibodies against RORα (sc-28612, Santa Cruz Biotechnology, Inc.)
and REV-ERBα (#2124, Cell Signaling Technology, Japan, K.K.). Chromatin/antibody complexes were extracted with a protein G agarose kit (Roche, Basel, Switzerland) . DNA was This article has not been copyedited and formatted. The final version may differ from this version. isolated with the Wizard SV Genomic DNA Purification System (Promega Corporation) and subjected to PCR using the following primer for the D-site of the DRD3 promoter region:
5′-CTCTCATACCATCGCATGT-3′ and 5′-GCACAAAAGGTCTCACTCCT-3′. DNA was amplified with a Go Taq Green Master Mix (Promega Corporation). The PCR products were run on a 2%
agarose gel. The gel was photographed with a digital camera after staining with ethidium bromide. For negative controls, chromatin immunoprecipitation was performed in the absence of antibody or in the presence of rabbit IgG. PCR products from these samples were not detectable by ethidium bromide staining. The relative ChIP PCR abundance was normalized to the corresponding input DNA levels.
Statistical analysis. The significance of the 24-h variations in each parameter was tested by a cosinor analysis with ChronoLab software. The rhythm characteristics that are estimated by this method include the acrophase (time of peak value in the fitted cosine function that is expressed as the lag in hours and minutes from midnight). P values that were determined from comparisons of the residuals before and after cosine curve fitting and that were less than 0.05 indicated the detection of a rhythm. The statistical significance of the differences among the groups was analyzed with ANOVA and Tukey's multiple comparison test. Probabilities that were less than 5% were considered significant.
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 1A) . In order to investigate the functional importance of these sequences for the expression of DRD3, we examined the influence of the overexpression of clock genes on endogenous mRNA expression levels in C-1300N cells. Although the overexpression of both BMAL1 and CLOCK or D-site-binding protein (DBP) had little effect on the expression of DRD3, the overexpression of RORα increased the levels of expression of endogenous DRD3 mRNA (Fig. 1B) . Transactivation of the wild-type (-2427)-Luc reporter by RORα was repressed by cotransfecting with REV-ERBα (Fig. 1C) . The transactivation effect of RORα had little effect on the transcriptional activity that was driven by the truncated promoter fragments (Fig. 1D) . Incubating wild-type (-2427)-Luc-transfected cells with RORα caused a 3.5-fold increase in promoter activity (Fig. 1E ), but this was attenuated by mutation of the ROR response element (RORE). are able to induce and/or synchronize circadian gene expression (Balsalobre et al., 2000a; 2000b) . Brief exposure of astrocytes to 50% FBS for 2 h induced the rhythmic expression of DRD3 mRNA ( Fig. 2A) . The bioluminescence oscillation that was driven by DRD3::Luc in the C-1300N cells was attenuated by transfection with REV-ERBα (Supplemental Fig. 3C ).
Role of REV-ERBα

Time dependency of REV-ERBα binding to the DRD3 promoter.
We determined the 24-h rhythm of the levels of expression of DRD3 mRNA in the ventral striatum. There was a significant 24-h variation in the mRNA levels of DRD3 in the ventral striatum, with higher levels during the light phase (P < 0.01; cosinor analysis, Fig. 3 ). Both RORα and REV-ERBα proteins were expressed in the mouse ventral striatum, and they showed a 24-h variation, with a peak This article has not been copyedited and formatted. The final version may differ from this version. occurring during the dark phase (P < 0.05, Fig. 4A ; P < 0.05, Fig. 4B ). However, the fold-change of the protein expression of REV-ERBα at ZT14 was significantly higher than that of RORα at ZT14 (Fig. 4C ). This CLOCK-regulated output pathway may be functionally important for the rhythmic expression of DRD3 mRNA in the ventral striatum. We investigated the temporal binding of endogenous RORα and REV-ERBα protein on the DRD3 promoter with a ChIP assay.
The RORE of the DRD3 promoter is located between 2231 bp and 2221 bp upstream from the transcription start site. RORα and REV-ERBα that bound to the DRD3 promoter containing RORE showed a time-dependent variation (Fig. 4D ). In addition, the binding levels of REV-ERBα at ZT14 were higher than those of RORα.
Influence of dosing time on the efficacy of 7-OH-DPAT on mouse locomotor activity.
We examined the 24-h rhythm of DRD3 protein levels in the mouse ventral striatum. Prior to the analysis of temporal expression profiles of DRD3 protein, we tested the specificity of anti-DRD3
antibody (sc-9114, Santa Cruz Biotechnology), because mature DRD3 protein is thought to be transformed into membrane after glycosylation. The bands of immature DRD3 protein (unglycosylation form) appeared around 50kDa. However, several bands were detected between 50-80 kDa (Supplemental Fig. 1A ). The bands detected above 50 kDa seemed to show glycosylation form of DRD3, since the bands were disappeared when the membrane fractions were treated with N-glycosidase (Supplemental Fig. 1B) . These results suggest that our used This article has not been copyedited and formatted. The final version may differ from this version. antibody (sc-9114) can recognize both glycosylation and unglycosylation forms of DRD3 protein.
The specificity of the antibody was also confirmed by both immunohistochemical and western blot analysis of NIH3T3 cells that were transfected with human DRD3 expression construct (Supplemental Fig. 1C) . The results of western blot analysis revealed that DRD3 protein levels increased during the dark phase (Fig. 5A) . Because the expression of DRD3 protein exhibited 24-h rhythm, we tested the influence of the dosing time on the efficacy of 7-OH-DPAT. The compound is a preferential DRD3 agonist and can inhibit locomotor activity. As shown in Fig. 5B , there was a significant dosing time-dependent difference in the activity counts after the 7-OH-DPAT injection. In mice injected with 7-OH-DPAT at ZT14, locomotor activity was decreased at all doses tested (10, 50, and 100 μ g/kg; P < 0.05). In addition, the effects of 7-OH-DPAT significantly increased in a concentration-dependent manner at ZT14. On the other hands, in the response at ZT2, locomotor activity was decreased with only the high 7-OH-DPAT dose of 100
Discussion
In this study, we confirmed that the expression of DRD3 in the mouse ventral striatum was under the control of the molecular organization of the circadian clock. DRD3, which is located in the ventral striatum, modulates dopamine turnover and emotion (Barik et al., 2005) . In addition, a recent study demonstrated that the expression of DRD3 shows a 24-h rhythm (Akhisaroglu et al., 2005) . We therefore further focused on the molecular mechanisms underlying the 24-h rhythm of DRD3.
The computer-aided analysis of the mouse DRD3 promoter identified an E-box element transfection of the neuroblastoma cell line with lipofection was very difficult. We thus confirmed the expression of DRD3 in astrocytes cells. DRD3 is highly expressed in astrocytes compared to neurons in the striatum (Miyazaki et al., 2004) . The expression of DRD3 was decreased in astrocyte cells transfected with siDRD3 (Supplemental Fig. 2A ). In addition, the expression of endogenous DRD3 in astrocyte cells was increased by overexpressed RORα as well as C-1300N cells experiments (Supplemental Fig. 2B ). Clock genes were rhythmically expressed in astrocytes (Prolo et al., 2005) . Therefore, we used primary astrocytes in this study. The oscillations in the expression of DRD3 mRNA in serum-shocked cells were modulated by the knockdown of REV-ERBα. Furthermore, the bioluminescence oscillation driven by Drd3::Luc in the C-1300N cells was diminished by the overexpression of REV-ERBα (Supplemental Fig. 3C ).
A recent study suggested that REV-ERBα plays a more important role than RORα in the transcriptional circuitry of the clock system. REV-ERBα and RORα regulate the expression of Bmal1 by binding to RORE. REV-ERBα is required for the rhythmic expression of Bmal1, while RORα is dispensable (Liu et al., 2008) . In addition, the 24-h rhythm of the expression of Bmal1 mRNA is blunted in REV-ERBα-mutant mice (Preitner et al., 2002) . Taken together, these findings suggest that REV-ERBα participates in the control of the rhythmic expression of DRD3 mRNA in vitro.
The results of the western blot analysis demonstrated that rhythmic patterns of REV-ERBα
This article has not been copyedited and formatted. The final version may differ from this version. These in vivo and in vitro data suggested that, when the binding amount of REV-ERBα was attenuated, RORα activated the expression of DRD3 mRNA. As a result, the expression of protein and mRNA of DRD3 exhibited a 24-h rhythm. However, the peak of DRD3 protein was 12 h later than the peak of DRD3 mRNA in the ventral striatum. Similar findings have been confirmed for different proteins, such as CRY2 and MetAP2 (Lee et al., 2001; Nakagawa et al., 2004) . CRY2 mRNA showed a peak at ZT2, and its protein showed a peak at ZT14. Although the This article has not been copyedited and formatted. The final version may differ from this version. μ g/kg did not affect the locomotor inhibition through DRD2, suggesting that low dosage of 7-OH-DPAT more selectively activates DRD3 than DRD2 or other receptors (Pritchard et al., 2003) . In addition, 7-OH-DPAT is engaged in activities, such as the inhibition of locomotor activity, without interacting with the 5-HT 1A receptor or modulating 5-HT release (Dekeyne et al., 2001) . Taken together, because DRD3 protein levels were higher at ZT14, a low 7-OH-DPAT dose (10 μ g/kg) may more activate DRD3 than DRD2 and higher dosage (50 μ g/kg, 100 μ g/kg) activate both DRD2 and DRD3, whereas at ZT2, when DRD3 protein levels are lower, the low dosage of 7-OH-DPAT was without effect on locomotor. These results suggested that the circadian rhythm of DRD3 protein was associated with the dosing time dependence of 7-OH-DPAT-induced locomotor hypoactivity.
Futher studies are required to clarify how DRD3 interact to regulate dosing time-dependent change in 7-OH-DPAT-induced locomotor hypoactivity.
In conclusion, this study suggested that RORα and REV-ERBα inversely regulate the This article has not been copyedited and formatted. The final version may differ from this version. transcription of DRD3 (Fig. 6) . Furthermore, the 24-h rhythm of DRD3 expression is likely to be a mechanism that underlies the time-dependent change in the efficacy of the DRD3 agonist, 7-OH-DPAT. Our present findings revealed that a molecular link between the circadian clock and the function of DRD3 in the ventral striatum acts as a modulator of the pharmacological actions of DRD3 agonists/antagonists.
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This article has not been copyedited and formatted. The final version may differ from this version. to nontreated wild-type (2427)-Luc. #, P < 0.05 compared to RORα-transfected wild-type-Luc. Transfected cells were treated with 50% fetal bovine serum for 2 h and subsequently incubated in serum-starved medium. The mRNA levels of DRD3 were determined from 24 h to 52 h after serum treatment.
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